Angiotensin II receptor blockers suppress the release of stromal cell-derived factor-1α from infarcted myocardium in patients with acute myocardial infarction.

[1]  K. Node,et al.  Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial. , 2017, Journal of cardiology.

[2]  Takuya Shimizu,et al.  Sustained myocardial production of stromal cell-derived factor-1α was associated with left ventricular adverse remodeling in patients with myocardial infarction. , 2015, American journal of physiology. Heart and circulatory physiology.

[3]  C. Specchia,et al.  Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction. , 2013, Cardiovascular research.

[4]  M. Gawaz,et al.  Platelet‐derived CXCL12 (SDF‐1α): basic mechanisms and clinical implications , 2013, Journal of thrombosis and haemostasis : JTH.

[5]  B. Jugdutt,et al.  Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction , 2013, Molecular and Cellular Biochemistry.

[6]  Zhangsuo Liu,et al.  Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats. , 2012, Diabetes research and clinical practice.

[7]  N. Frangogiannis.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[8]  M. Hristov,et al.  Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. , 2011, Journal of the American College of Cardiology.

[9]  N. Frangogiannis.  The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. , 2011, Journal of the American College of Cardiology.

[10]  M. Pittet,et al.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. , 2010, Circulation.

[11]  V. Hombach,et al.  Glucagon-like peptide-1(1-37) inhibits chemokine-induced migration of human CD4-positive lymphocytes , 2010, Cellular and Molecular Life Sciences.

[12]  H. Daida,et al.  Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[13]  P. Altman,et al.  Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. , 2010, The American journal of pathology.

[14]  Yao Sun.  Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction. , 2010, Journal of molecular and cellular cardiology.

[15]  S. Ogawa,et al.  Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[16]  S. Yusuf,et al.  RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection , 2008, Clinical Research in Cardiology.

[17]  James W. Smyth,et al.  Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction , 2008, Circulation.

[18]  Y. Saitoh,et al.  Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. , 2007, Journal of the American College of Cardiology.

[19]  H. White,et al.  Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction , 2007, Vascular health and risk management.

[20]  H. Haider,et al.  Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. , 2007, Journal of molecular and cellular cardiology.

[21]  Takamitsu Nakamura,et al.  Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[22]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[23]  H. Ishizaka,et al.  Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction. , 2005, International journal of cardiology.

[24]  H. Sarau,et al.  Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines , 2004, Circulation.

[25]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[26]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[27]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[28]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.

[29]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[30]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[31]  K. Nakao,et al.  Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.

[32]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[33]  K. Swedberg,et al.  Short- and long-term neurohormonal activation following acute myocardial infarction. , 1993, American heart journal.

[34]  G. Lamas,et al.  Activation of neurohumoral systems in postinfarction left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.

[35]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[36]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[37]  Mika Futamata,et al.  High levels of stromal cell-derived factor-1α predict secondary cardiac events in stable patients with a history of myocardial infarction. , 2017, Journal of cardiology.

[38]  Yujie Zhou,et al.  Role of stromal cell-derived factor-1 in patients with non-ST elevation acute coronary syndrome. , 2014, International heart journal.

[39]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[40]  ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations. , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[41]  A. Carayon,et al.  , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of , 1999 .

[42]  Stromal Cell–Derived Factor-1 (cid:1) in Unstable Angina Potential Antiinflammatory and Matrix-Stabilizing Effects , 2022 .